Acadia Pharmaceuticals reported $-43398000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Aptinyx Inc APTX:US $ -19819000 5.59M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Cara Therapeutics CARA:US $ -30745000 7.44M
Cytokinetics CYTK:US $ -61.55M 14.45M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 7776M 515M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Prothena PRTA:US $ 27.9M 59.97M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Vanda Pharmaceuticals VNDA:US $ 12.6M 2.18M
YTE INCY:US $ 199.6M 31.06M
Zogenix ZGNX:US $ -58.9M 3.27M